SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-677524
Filing Date
2016-08-10
Accepted
2016-08-10 07:31:25
Documents
55
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d201049d10q.htm 10-Q 501677
2 EX-10.26 d201049dex1026.htm EX-10.26 3203
3 EX-10.27 d201049dex1027.htm EX-10.27 49046
4 EX-31.1 d201049dex311.htm EX-31.1 9198
5 EX-31.2 d201049dex312.htm EX-31.2 9195
6 EX-32.1 d201049dex321.htm EX-32.1 5413
  Complete submission text file 0001193125-16-677524.txt   2518852

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aldx-20160630.xml EX-101.INS 334748
8 XBRL TAXONOMY EXTENSION SCHEMA aldx-20160630.xsd EX-101.SCH 33368
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20160630_cal.xml EX-101.CAL 40142
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20160630_def.xml EX-101.DEF 90275
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20160630_lab.xml EX-101.LAB 276381
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20160630_pre.xml EX-101.PRE 182063
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 161819969
SIC: 2834 Pharmaceutical Preparations